A phase II study of Homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: a pediatric oncology group study.
about
Homoharringtonine: a new treatment option for myeloid leukemia.Complementary therapies and childhood cancer.Drug monographs: cabozantanib and omacetaxine.Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China.
P2860
A phase II study of Homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: a pediatric oncology group study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A phase II study of Homoharrin ...... ediatric oncology group study.
@ast
A phase II study of Homoharrin ...... ediatric oncology group study.
@en
A phase II study of Homoharrin ...... ediatric oncology group study.
@nl
type
label
A phase II study of Homoharrin ...... ediatric oncology group study.
@ast
A phase II study of Homoharrin ...... ediatric oncology group study.
@en
A phase II study of Homoharrin ...... ediatric oncology group study.
@nl
prefLabel
A phase II study of Homoharrin ...... ediatric oncology group study.
@ast
A phase II study of Homoharrin ...... ediatric oncology group study.
@en
A phase II study of Homoharrin ...... ediatric oncology group study.
@nl
P2093
P2860
P356
P1476
A phase II study of Homoharrin ...... ediatric oncology group study.
@en
P2093
P2860
P304
P356
10.1002/MPO.1177
P577
2001-08-01T00:00:00Z